Safety study of moxifloxacin in children with severe refractory Mycoplasma pneumoniae pneumonia.
Sign Up to like & getrecommendations! Published in 2023 at "Pediatric pulmonology"
DOI: 10.1002/ppul.26426
Abstract: BACKGROUND With the increase in macrolide-resistant M. pneumoniae infections, off-label use is difficult to avoid. This study assessed the safety of moxifloxacin in pediatric patients with severe refractory M. pneumoniae pneumonia (SRMPP). METHODS We retrospectively… read more here.
Keywords: pneumoniae pneumonia; group; moxifloxacin; severe refractory ... See more keywords
Efficacy of anti-TNF alpha in severe and refractory major vessel involvement of Behcet's disease: A multicenter observational study of 18 patients.
Sign Up to like & getrecommendations! Published in 2018 at "Clinical immunology"
DOI: 10.1016/j.clim.2018.08.004
Abstract: OBJECTIVE To describe the outcome and tolerance in patients treated with anti-TNFα in severe and refractory major vessel disease in Behçet's disease (BD). METHODS A multicenter study evaluating 18 refractory BD patients with major vessel… read more here.
Keywords: major vessel; tnf; disease; anti tnf ... See more keywords
IVIG – A cure to severe refractory NAP-1 Clostridium difficile colitis? A case of successful treatment of severe infection, which failed standard therapy including fecal microbiota transplants and fidaxomicin☆
Sign Up to like & getrecommendations! Published in 2017 at "IDCases"
DOI: 10.1016/j.idcr.2017.03.002
Abstract: The mainstay treatment of Clostridium difficile infections (CDI) is antimicrobials with growing support for fecal microbiota transplants. We report the first case of an elderly man with severe refractory NAP-1 pseudomembranous CDI who failed all… read more here.
Keywords: refractory nap; clostridium difficile; treatment; severe refractory ... See more keywords
Effect of avatrombopag in the management of severe and refractory chemotherapy-induced thrombocytopenia (CIT) in patients with solid tumors
Sign Up to like & getrecommendations! Published in 2022 at "Platelets"
DOI: 10.1080/09537104.2022.2026910
Abstract: Abstract Chemotherapy-induced thrombocytopenia (CIT) is a common complication in cancer patients, especially after multiple cycles of chemotherapy, which leads to the delayed treatment or reduced dosage. The treatment of CIT is limited for refractory and… read more here.
Keywords: refractory; cit; severe refractory; treatment ... See more keywords
Goniotomy Using the Kahook Dual Blade in Severe and Refractory Glaucoma: 6-Month Outcomes
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Glaucoma"
DOI: 10.1097/ijg.0000000000001019
Abstract: Purpose: The purpose of the study is to describe short-term efficacy and safety of goniotomy with trabecular meshwork excision using the Kahook Dual Blade (KDB, New World Medical Inc., Rancho Cucamonga, CA) in patients with… read more here.
Keywords: using kahook; severe refractory; kahook dual; refractory glaucoma ... See more keywords
AB0531 GOLIMUMAB IN THE TREATMENT OF SEVERE AND/OR REFRACTORY VASCULO-BEHÇET’S DISEASE: A SINGLE-CENTRE EXPERIENCE IN CHINA
Sign Up to like & getrecommendations! Published in 2020 at "Annals of the Rheumatic Diseases"
DOI: 10.1136/annrheumdis-2020-eular.2272
Abstract: Background: Vascular involvement is one of the leading causes of mortality and morbidity in Behcet’s Disease (BD)1. Surgical treatments are difficult for Vaculo-BD (VBD) patients due to the high risk of serious postoperative complications without… read more here.
Keywords: severe refractory; treatment severe; vbd; disease ... See more keywords
Daratumumab as a rescue therapy in severe refractory anti-SRP immune-mediated necrotising myopathy
Sign Up to like & getrecommendations! Published in 2023 at "Annals of the Rheumatic Diseases"
DOI: 10.1136/ard-2022-223541
Abstract: REFERENCES 1 Petri M, Landy H, Clowse MEB, et al. Belimumab use during pregnancy: a summary of birth defects and pregnancy loss from belimumab clinical trials, a pregnancy registry and postmarketing reports. Ann Rheum Dis… read more here.
Keywords: anti srp; daratumumab rescue; therapy severe; severe refractory ... See more keywords
Partial Splenic Embolization for the Management of Severe Refractory Thrombocytopenia in Antiphospholipid Syndrome: A Case Report and Literature Review
Sign Up to like & getrecommendations! Published in 2022 at "Vascular and Endovascular Surgery"
DOI: 10.1177/15385744211072682
Abstract: Antiphospholipid syndrome is an autoimmune condition characterized by arteriovenous thromboembolic events. Thrombocytopenia is a common finding among these patients and is typically of mild severity not requiring any treatment. However, severe cases of thrombocytopenia should… read more here.
Keywords: refractory; partial splenic; splenic embolization; antiphospholipid syndrome ... See more keywords
Dupilumab and tezepelumab in severe refractory asthma: new opportunities
Sign Up to like & getrecommendations! Published in 2022 at "Therapeutic Advances in Chronic Disease"
DOI: 10.1177/20406223221097327
Abstract: Bronchial asthma is a chronic inflammatory condition with increasing prevalence worldwide that may present as heterogeneous phenotypes defined by the T2-mediated pattern of airway inflammation T2-high and T2-low asthma. Severe refractory asthma includes a subset… read more here.
Keywords: dupilumab tezepelumab; refractory; severe refractory; refractory asthma ... See more keywords
Bronchial thermoplasty in patients with dynamic hyperinflation: results from the proof-of-concept HEAT trial
Sign Up to like & getrecommendations! Published in 2020 at "European Respiratory Journal"
DOI: 10.1183/13993003.01616-2020
Abstract: Severe refractory asthma affects 3–5% of asthmatic patients, but represents 50–80% of asthma-related healthcare costs [1]. Although therapies targeting IgE and, more recently, IL5 and IL4/13 have recently gained approval for the treatment of severe… read more here.
Keywords: dynamic hyperinflation; bronchial thermoplasty; refractory asthma; severe refractory ... See more keywords
Effectiveness of Switching to Benralizumab in Severe Refractory Eosinophilic Asthma
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Asthma and Allergy"
DOI: 10.2147/jaa.s358705
Abstract: Purpose Benralizumab is a monoclonal antibody that targets the α subunit of the IL-5 receptor. Clinical trials have demonstrated the efficacy of this agent with respect to lung function and symptom control in patients with… read more here.
Keywords: eosinophilic asthma; refractory eosinophilic; control; severe refractory ... See more keywords